-- 週三盤前交易中，醫療保健類股小幅走高，道富醫療保健精選行業SPDR ETF (XLV)上漲0.1%，iShares生物科技ETF (IBB)上漲1%。 諾和諾德 (NVO) 股價盤前上漲超過6%，此前該公司公佈的第一季獲利和營收均高於預期，並上調了2026年調整後銷售成長預期。
Related Articles
Australia
Blue Moon Metals Closes C$156.23-Million Bought-Deal Share Offerings; Shares up 5.6%
Blue Moon Metals (MOON.V) on Wednesday said it closed a bought-deal public offering of shares and concurrent bought deal private placement, raising C$156.23 million.The company sold underwriters 10.63-million shares priced at C$10.00 in the public offering, raising C$106.23 million, including the partial exercise of the underwriters' over-allotment option.The concurrent private placement sold five-million shares at the same price for proceeds of C$50 million.The proceeds are expected to be used for construction of the Nussir and Blue Moon projects, development capital for the Springer Tungsten and Apex projects, additional exploration at the foregoing projects, working capital, U.S. growth activities and general and administrative and corporate activities.The company's shares were last seen up $0.51 to $9.60 on the TSX Venture Exchange.Price: $9.60, Change: $+0.51, Percent Change: +5.61%
$MOON.V
Australia
Rothschild & Co Redburn Adjusts Live Nation Entertainment Price Target to $195 From $193
Live Nation Entertainment (LYV) has an average rating of overweight and mean price target of $185.78, according to analysts polled by FactSet.Price: $168.56, Change: $+11.30, Percent Change: +7.19%
$LYV
Australia
Jefferies Raises Williams Price Target to $87 From $83
Williams (WMB) has an average rating of overweight and mean price target of $82.14, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $74.38, Change: $-1.74, Percent Change: -2.29%
$WMB